Nasdaq · Biotech stocks database
MRVI (Maravai LifeSciences Holdings Inc.) stock: $7.52, $1.95B market cap, $73.0M cash, $2.03B EV, $1.19B fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Our customers include biopharmaceutical companies, emerging biotech firms, life science research organizations, academic research institutions and diagnostics companies. Our comprehensive product portfolio addresses the critical stages of biopharmaceutical development, offering: • complex nucleic acids for therapeutic, vaccine, and diagnostic applications; • custom enzymes for research and diagnostic use; and • antibody-based solutions to detect impurities during the production of biopharmaceutical products.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $73.0M |
|---|---|
| Debt | $147.2M |
| Net cash | -$74.2M |
| Enterprise value | $2,026.9M |
| Basic shares | 149.0M shares |
| Fully diluted shares | 158.8M shares |
| Fully diluted market cap | $1,194.0M |
| Cash per share | $0.49 |
| Quarterly burn | +$4.0M generated |
Cash figures as of 2026-09-30. Database snapshot: 2026-11-07.
Cap table as of 2026-06-30.
Loading MRVI daily closes…